SequelSEC

Nu-Med Plus, Inc. NUMD

Surgical & Medical Instruments & Apparatus · CIK 0001543637 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2020-12-31
Operating income
-$1.99M
Fiscal year ended 2020-12-31
Free cash flow
Unavailable
Fiscal year ended 2020-12-31

Nu-Med Plus, Inc. (NUMD) reported revenue of $0 and net income of -$2.01M for the fiscal year ended 2020-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Nu-Med Plus, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Nu-Med Plus, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$0$0$0$0$0$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$1.99M-$1.02M-$1.17M-$466.52K-$1.22M-$946.48K-$1.15M
Net income-$2.01M-$1.04M-$1.19M$3.58M$9.65M-$8.88M-$1.19M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 54.51Mshares 45.55Mshares 41.79Mshares 71.86Mshares 75.03Mshares 35.40MUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expense$0$0$100$0$0$0$0
Diluted EPS$-0.04$-0.02$-0.03$0.05$0.13$-0.25Unavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$58.26K$76.13K$128.10K$64.96K$62.17K$34.88K$60.17K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Nu-Med Plus, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Cash & equivalents$188.51K$7.08K$167.51K$351.04K$12.45K$30.90K$56.27K
Total assets$557.14K$45.78K$423.02K$406.72K$35.53K$75.94K$213.06K
Current assets$537.52K$13.96K$386.22K$360.21K$12.45K$45.72K$172.12K
Total liabilities$89.43K$416.21K$374.49K$338.48K$4.47MUnavailableUnavailable
Current liabilities$80.05K$416.21K$374.49K$327.91K$4.47M$15.30M$266.83K
Total equity incl. NCI$467.70K-$370.43K$48.53K$68.24K-$4.44M-$15.22M-$7.11M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$26.05K$39.82K$9.78K$0$5.06K$6.40K$0

Cash flow

Nu-Med Plus, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating cash flow-$414.80K-$567.34K-$467.57K-$430.51K-$180.26K-$182.91K-$158.26K
Capital expendituresUnavailable$0-$5.02K$0Unavailable$0-$1.10K
Investing cash flow$0$0-$5.02K$0$0$0-$1.10K
Financing cash flow$596.23K$406.91K$289.06K$769.10K$161.81K$157.54K$202.40K
Net change in cash$181.43K-$160.43K-$183.53K$338.59K-$18.45K-$25.37K$43.04K
Stock-based compensation$961.15K$200.00K$232.06K$0$0$409$10.90K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$11.79K$13.37K$14.74K$12.54K$7.15K$7.15K$6.96K

Derived

Nu-Med Plus, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Free cash flowUnavailableUnavailableUnavailable-$430.51KUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio6.72x0.03x1.03x1.10x0.00x0.00x0.65x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NUMD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-K · Filed 2025-03-31View SEC filing
10-Q · Filed 2024-11-14View SEC filing
10-Q · Filed 2024-05-15View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.